This article was originally published in The Gray Sheet
Executive SummaryNames Joseph Laptewicz president and CEO, effective Oct. 1. Laptewicz takes over duties from company founder Donald Maurer, who remains chairman of Empi. Laptewicz has served in management positions at Pfizer since 1972, most recently as president and CEO of its Schneider subsidiary. The appointment of Laptewicz will "strengthen" Empi's top management and allow Maurer to "focus more intensively" on the firm's "new products and long-term strategies," such as diversification, the Empi chairman said
You may also be interested in...
The fast-dissolving tablet will launch in early March. Its list price is not available but based on pricing for Allergan’s oral anti-CGRP Ubrelvy, ICER has said Biohaven’s rimegepant is likely to be cost-effective.
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.